Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) continues to
leverage its drug delivery platform technology in exciting new markets. An
article discussing the company reads, “It has patents granted in the U.S. and
Australia for applications of its DehydraTECH™ technology. Moreover, the
company has many patents pending in over 40 nations. Lexaria Bioscience’s
business strategy involves expanding the applicability of its technology within
and beyond the cannabinoid sector. Recently upgraded to the OTC Markets’ OTCQX
Best Market, Lexaria Bioscience is based in Kelowna, British Columbia. … The
DehydraTECH™ drug delivery platform promotes healthier ingestion methods. It
considerably improves the body’s ability to absorb cannabinoids, vitamins,
nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine,
drugs, supplements and other valuable molecules. The platform boosts the
performance of useful compounds in ingestible products across the taste, smell,
speed of action, bioabsorption and bioavailability categories.”
To view the full article, visit http://ibn.fm/KXUJ6
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important taste-masking
benefits, for orally administered bioactive molecules including cannabinoids,
vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other
molecules. For more information, visit the company’s website at www.LexariaBioscience.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer excellent
growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment